Laurel Cherian , Puja Agarwal , Klodian Dhana , Vincent Carey , Mark A. Espeland , Nancy Laranjo , Xavier Reilly , Cheng Hong , Pyone Maung , Chiquia Hollings , Beth Lukaszewicz , Jennifer Ventrelle , Jameszetta James , Amy Tran , Santosh Basapur , Thomas Holland , Kristin R. Krueger , Xiaoran Liu , Dixon Yang , James R. Brorson , Neelum T. Aggarwal
{"title":"Nutrition effects on brain outcomes and recovery in stroke after hospitalization (NOURISH): Randomized controlled trial protocol and rationale","authors":"Laurel Cherian , Puja Agarwal , Klodian Dhana , Vincent Carey , Mark A. Espeland , Nancy Laranjo , Xavier Reilly , Cheng Hong , Pyone Maung , Chiquia Hollings , Beth Lukaszewicz , Jennifer Ventrelle , Jameszetta James , Amy Tran , Santosh Basapur , Thomas Holland , Kristin R. Krueger , Xiaoran Liu , Dixon Yang , James R. Brorson , Neelum T. Aggarwal","doi":"10.1016/j.cct.2025.108108","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Risk of dementia doubles after stroke. There is limited information on reduction of risk, but diet is a significant modifiable risk factor for both vascular health and cognition.</div></div><div><h3>Objective</h3><div><strong>N</strong>utrition effects on brain <strong>Ou</strong>tcomes and <strong>R</strong>ecovery <strong>I</strong>n <strong>S</strong>troke after <strong>H</strong>ospitalization (NOURISH; registration no. <span><span>NCT04337255</span><svg><path></path></svg></span>) is a phase III randomized controlled trial designed to test the effects of the MIND diet on changes in cognition following an acute ischemic stroke.</div></div><div><h3>Study methods</h3><div>Eligible participants aged 55 and older were randomized to either the MIND diet intervention facilitated by credentialled nutritionists plus post-stroke care (Coach) or a post-stroke care intervention led by health educators (Self) for 24–36 months. Repeated assessments included anthropometric measurements, cognitive testing, blood and urinary biomarkers, and a variety of validated post-stroke outcome measures and follow-up visits for up to 3 years, with MRI scans conducted on a subset of participants at baseline and the study's end.</div><div>Unique features of this study include:<ul><li><span>•</span><span><div>Lifestyle and diet counseling to support the adoption of the MIND diet post-stroke in the Coach group</div></span></li><li><span>•</span><span><div>Post-stroke counseling which includes counseling for reduced sodium and saturated fat consumption by both groups</div></span></li><li><span>•</span><span><div>90 days of delivered meals</div></span></li><li><span>•</span><span><div>Detailed cognitive assessments, tracking longitudinal changes in cognitive function post-stroke</div></span></li><li><span>•</span><span><div>MRI scans to assess brain structure, potentially providing evidence of diet-related effects on the brain</div></span></li></ul></div></div><div><h3>Conclusions</h3><div>This study will evaluate the MIND diet intervention in preventing cognitive impairment in older adults after acute stroke. Findings will provide insights for the development of dietary guidelines for post-stroke care.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"158 ","pages":"Article 108108"},"PeriodicalIF":1.9000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425003027","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Risk of dementia doubles after stroke. There is limited information on reduction of risk, but diet is a significant modifiable risk factor for both vascular health and cognition.
Objective
Nutrition effects on brain Outcomes and Recovery In Stroke after Hospitalization (NOURISH; registration no. NCT04337255) is a phase III randomized controlled trial designed to test the effects of the MIND diet on changes in cognition following an acute ischemic stroke.
Study methods
Eligible participants aged 55 and older were randomized to either the MIND diet intervention facilitated by credentialled nutritionists plus post-stroke care (Coach) or a post-stroke care intervention led by health educators (Self) for 24–36 months. Repeated assessments included anthropometric measurements, cognitive testing, blood and urinary biomarkers, and a variety of validated post-stroke outcome measures and follow-up visits for up to 3 years, with MRI scans conducted on a subset of participants at baseline and the study's end.
Unique features of this study include:
•
Lifestyle and diet counseling to support the adoption of the MIND diet post-stroke in the Coach group
•
Post-stroke counseling which includes counseling for reduced sodium and saturated fat consumption by both groups
•
90 days of delivered meals
•
Detailed cognitive assessments, tracking longitudinal changes in cognitive function post-stroke
•
MRI scans to assess brain structure, potentially providing evidence of diet-related effects on the brain
Conclusions
This study will evaluate the MIND diet intervention in preventing cognitive impairment in older adults after acute stroke. Findings will provide insights for the development of dietary guidelines for post-stroke care.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.